Verrica Pharmaceuticals Inc. (VRCA) DCF Valuation

Verrica Pharmaceuticals Inc. (VRCA) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Verrica Pharmaceuticals Inc. (VRCA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the Verrica Pharmaceuticals Inc. (VRCA) DCF Calculator! Explore authentic Verrica financials, adjust growth projections and expenses, and instantly observe how modifications affect the intrinsic value of Verrica Pharmaceuticals Inc. (VRCA).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 12.0 9.0 5.1 4.3 3.5 2.9 2.4 2.0
Revenue Growth, % 0 0 0 -24.73 -43.27 -17 -17 -17 -17 -17
EBITDA -30.1 -39.4 -30.3 -21.6 -62.2 -.9 -.7 -.6 -.5 -.4
EBITDA, % 100 100 -252.61 -239.12 -1213.84 -20 -20 -20 -20 -20
Depreciation .3 .2 .5 .7 .8 1.9 1.6 1.3 1.1 .9
Depreciation, % 100 100 3.93 7.95 16.32 45.64 45.64 45.64 45.64 45.64
EBIT -30.3 -39.7 -30.8 -22.3 -63.0 -.9 -.7 -.6 -.5 -.4
EBIT, % 100 100 -256.54 -247.07 -1230.15 -20 -20 -20 -20 -20
Total Cash 62.0 65.5 70.4 34.3 69.5 4.3 3.5 2.9 2.4 2.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .5 4.4
Account Receivables, % 100 100 0 5.39 86.18
Inventories .0 .0 .0 -.5 1.0 1.8 1.5 1.3 1.0 .9
Inventories, % 100 100 0 -5.39 19.95 42.91 42.91 42.91 42.91 42.91
Accounts Payable 1.2 .3 .8 .5 2.5 2.2 1.8 1.5 1.3 1.1
Accounts Payable, % 100 100 7.04 5.61 48.09 52.15 52.15 52.15 52.15 52.15
Capital Expenditure -.7 -1.5 -.9 -.3 -.4 -.2 -.1 -.1 -.1 -.1
Capital Expenditure, % 100 100 -7.36 -3.34 -7.06 -3.55 -3.55 -3.55 -3.55 -3.55
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -30.1 -42.3 -34.1 -25.2 -63.0 -.8 -.7 -.6 -.5 -.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -29.3 -44.3 -34.1 -25.1 -66.0 1.8 1.1 .9 .8 .6
WACC, % 9.72 9.77 9.77 9.77 9.77 9.76 9.76 9.76 9.76 9.76
PV UFCF
SUM PV UFCF 4.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 1
Terminal Value 9
Present Terminal Value 5
Enterprise Value 10
Net Debt -24
Equity Value 34
Diluted Shares Outstanding, MM 45
Equity Value Per Share 0.74

What You Will Get

  • Comprehensive VRCA Financials: Access to historical and projected data for precise valuation.
  • Customizable Variables: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Intrinsic value and NPV are calculated automatically and updated dynamically.
  • Scenario Analysis: Evaluate various scenarios to assess Verrica's future performance.
  • User-Friendly Interface: Designed for industry experts while remaining approachable for newcomers.

Key Features

  • Comprehensive Data: Verrica Pharmaceuticals Inc.'s historical financials and anticipated forecasts.
  • Customizable Parameters: Adjust inputs such as WACC, tax rates, revenue growth, and EBITDA margins.
  • Real-Time Insights: View the intrinsic value of Verrica Pharmaceuticals Inc. recalculated instantly.
  • Intuitive Visualizations: Dashboard charts present valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based VRCA DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
  3. Instant Calculations: The model automatically recalculates Verrica Pharmaceuticals' intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial strategy.

Why Choose This Calculator for Verrica Pharmaceuticals Inc. (VRCA)?

  • Accuracy: Utilizes real Verrica financial data to ensure precise calculations.
  • Flexibility: Allows users to easily test and adjust inputs according to their needs.
  • Time-Saving: Avoid the complexities of creating a financial model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Designed for simplicity, making it accessible for users with varying levels of financial knowledge.

Who Should Use This Product?

  • Investors: Accurately assess Verrica Pharmaceuticals Inc.'s (VRCA) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
  • Consultants: Easily customize the template for client valuation reports related to Verrica Pharmaceuticals Inc. (VRCA).
  • Entrepreneurs: Acquire knowledge on financial modeling practices employed by leading pharmaceutical companies.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques in the pharmaceutical sector.

What the Template Contains

  • Pre-Filled DCF Model: Verrica Pharmaceuticals Inc. (VRCA)’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Verrica Pharmaceuticals Inc. (VRCA)’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.